Robert Cantu
Psychiatry · Austin, TXNPI 1891771499
Payments from drug & device makers
Across 212 payments — averaging $26.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Axsome Therapeutics, Inc.$671
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$648
- Ironshore Pharmaceuticals Inc.$618
- Eisai Inc.$598
- Otsuka America Pharmaceutical, Inc.$428
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,57998%
- Education$962%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $1,008 |
| Axsome Therapeutics, Inc. | 26 | $671 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $648 |
| Ironshore Pharmaceuticals Inc. | 21 | $618 |
| Eisai Inc. | 15 | $598 |
| Otsuka America Pharmaceutical, Inc. | 16 | $428 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $332 |
| Johnson & Johnson | 11 | $255 |
| Vanda Pharmaceuticals Inc. | 9 | $169 |
| Lundbeck LLC | 9 | $144 |
| Supernus Pharmaceuticals, Inc. | 2 | $138 |
| Idorsia Pharmaceuticals US Inc | 2 | $133 |
| Lilly USA, LLC | 1 | $94 |
| Jazz Pharmaceuticals Inc. | 4 | $84 |
| Bausch Health US, LLC | 4 | $71 |
| Harmony Biosciences LLC | 3 | $65 |
| Arbor Pharmaceuticals, Inc. | 3 | $63 |
| Shire North American Group Inc | 2 | $36 |
| Corium, LLC | 2 | $34 |
| Neurocrine Biosciences, Inc. | 2 | $32 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,674 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DayvigoLemborexant | 21 | $6,854 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,286 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 15 | $4,442 |
| Duloxetine Hcl | 78 | $1,627 |
| Mirtazapine | 45 | $986 |
| Bupropion XlBupropion Hcl | 45 | $967 |
| Lurasidone Hcl | 16 | $789 |
| Naltrexone Hcl | 15 | $611 |
| Clonazepam | 27 | $488 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 17 | $483 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $456 |
| Lorazepam | 13 | $446 |
| Alprazolam | 59 | $355 |
| Trazodone Hcl | 41 | $339 |
| Olanzapine | 13 | $312 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Eisai Inc.Dayvigo | $598 | $6,85421 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $332 | $6,28613 claims |
| Lilly USA, LLCOlanzapine | $94 | $31213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Austin
- David BrownAustin$15.8M
- Divyansu PatelAustin$2.8M
- Donald GarciaAustin$2.8M
- Arvinder Pal WaliaAustin$2.5M
- Charles SweetAustin$520K
- Charles NemeroffAustin$429K
- Scott BartleyDallas$42.7M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.